TY - JOUR
T1 - Blood pressure recordings during hemodialysis access interventions
T2 - Implications for acute management
AU - Asif, Arif
AU - Castro, Hector
AU - Waheed, Ahmed Ameen
AU - Kumar, Vishesh
AU - Haqqie, Syed S.
AU - Siskin, Gary
AU - Mathew, Roy O.
AU - Mason, Darius
AU - Vachharajani, Tushar
AU - Nayer, Ali
AU - Merrill, Donna
AU - Akmal, Muhammad Ut
AU - Salman, Loay
PY - 2013/7/1
Y1 - 2013/7/1
N2 - A retrospective study evaluating the pattern of blood pressure and its related complications before, during, and after percutaneous hemodialysis interventions was performed in patients presenting with asymptomatic hypertension. Hemodialysis patients undergoing percutaneous interventions including tunneled hemodialysis catheter insertion, percutaneous balloon angioplasty and thrombectomy procedure, and stage II hypertension (systolic blood pressure ≥160 mmHg) were included in this analysis. Blood pressure medications were not used while midazolam and fentanyl were routinely administered. Patients were followed for up to 4 weeks to monitor any complications. The mean blood pressure before, during, and after the procedures were 185 ± 18/96 ± 14, 172 ± 22/92 ± 15, and 153 ± 25/87 ± 14, respectively. There was a statistically significant difference between the blood pressure readings before and after the procedure (before = 185 ± 18/96 ± 14, after = 153 ± 25/87 ± 14; p = 0.001). None of the patients had a stroke, myocardial infarction, or acute pulmonary edema before, during, or after the procedure or during the 4-week follow-up period. A significant reduction in blood pressure was observed after the procedure without the administration of any antihypertensive medication. These results suggest that the reduction in blood pressure observed after percutaneous dialysis access interventions (particularly in the presence of midazolam and fentanyl) may make it unnecessary to treat asymptomatic hypertension prior to these procedures.
AB - A retrospective study evaluating the pattern of blood pressure and its related complications before, during, and after percutaneous hemodialysis interventions was performed in patients presenting with asymptomatic hypertension. Hemodialysis patients undergoing percutaneous interventions including tunneled hemodialysis catheter insertion, percutaneous balloon angioplasty and thrombectomy procedure, and stage II hypertension (systolic blood pressure ≥160 mmHg) were included in this analysis. Blood pressure medications were not used while midazolam and fentanyl were routinely administered. Patients were followed for up to 4 weeks to monitor any complications. The mean blood pressure before, during, and after the procedures were 185 ± 18/96 ± 14, 172 ± 22/92 ± 15, and 153 ± 25/87 ± 14, respectively. There was a statistically significant difference between the blood pressure readings before and after the procedure (before = 185 ± 18/96 ± 14, after = 153 ± 25/87 ± 14; p = 0.001). None of the patients had a stroke, myocardial infarction, or acute pulmonary edema before, during, or after the procedure or during the 4-week follow-up period. A significant reduction in blood pressure was observed after the procedure without the administration of any antihypertensive medication. These results suggest that the reduction in blood pressure observed after percutaneous dialysis access interventions (particularly in the presence of midazolam and fentanyl) may make it unnecessary to treat asymptomatic hypertension prior to these procedures.
UR - http://www.scopus.com/inward/record.url?scp=84880702745&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880702745&partnerID=8YFLogxK
U2 - 10.1111/sdi.12083
DO - 10.1111/sdi.12083
M3 - Article
C2 - 23551213
AN - SCOPUS:84880702745
VL - 26
SP - E30-E32
JO - Seminars in Dialysis
JF - Seminars in Dialysis
SN - 0894-0959
IS - 4
ER -